Tumori Journal

Papers
(The H4-Index of Tumori Journal is 10. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-03-01 to 2024-03-01.)
ArticleCitations
Unexpected detection of SARS-CoV-2 antibodies in the prepandemic period in Italy96
Unknown SARS-CoV-2 pneumonia detected by PET/CT in patients with cancer28
Response of a comprehensive cancer center to the COVID-19 pandemic: the experience of the Fondazione IRCCS–Istituto Nazionale dei Tumori di Milano26
A multicenter phase 2 single arm study of cabozantinib in patients with advanced or unresectable renal cell carcinoma pre-treated with one immune-checkpoint inhibitor: The BREAKPOINT trial (Meet-Uro t15
Adnexal masses in pregnancy: an updated review on diagnosis and treatment14
Systematic review of health-related quality of life following thyroid cancer14
To a new normal in radiation oncology: looking back and planning forward13
Telemedicine for management of patients with lung cancer during COVID-19 in an Italian cancer institute: SmartDoc Project13
Gastrointestinal stromal tumors: relationship between preoperative CT features and pathologic risk stratification12
Patient-reported pain and other symptoms among breast cancer survivors: prevalence and risk factors12
Clinical significance of circPVT1 in patients with non-small cell lung cancer who received cisplatin combined with gemcitabine chemotherapy10
Childhood cancer in Italy: background, goals, and achievements of the Italian Paediatric Hematology Oncology Association (AIEOP)10
Prognostic value of advanced lung cancer inflammation index in patients with colorectal cancer liver metastases undergoing surgery10
Management of lymphoma survivor patients in Italy: an evaluation by Fondazione Italiana Linfomi10
0.038027048110962